InnovAge Holding Corp. filings document the reporting framework for a Nasdaq-listed healthcare services company built around the Program of All-inclusive Care for the Elderly (PACE). Form 8-K reports furnish quarterly operating results, financial-condition updates, Regulation FD investor presentations, guidance-related materials, and governance events such as director appointments and executive transitions.
Proxy materials describe annual meeting matters, classified-board elections, committee governance, executive and director compensation, stockholder voting procedures, and auditor ratification. The filings also identify InnovAge common stock on the Nasdaq Global Select Market and include emerging-growth-company status, common-stock registration details, capital-structure information, and public-company reporting obligations tied to its PACE care model.
InnovAge Holding Corp. (INNV) received notice that investment entities affiliated with Welsh, Carson, Anderson & Stowe reported an indirect disposition of 411,515 shares of common stock on September 3, 2026, reflecting a distribution by TCO Group Holdings, L.P. to one of its limited partners as consideration for that partner’s interest. Following this restructuring-related distribution, the affiliated holders continue to report indirect ownership of 112,576,555 shares of InnovAge common stock, with complex partnership and management entities disclaiming beneficial ownership except to the extent of their pecuniary interests. No transactions were reported under a Rule 10b5-1 trading plan.
InnovAge Holding Corp. (INNV) reported strong fiscal 2026 improvement, with total revenue of $989.7 million, up 15.9% from $853.7 million in 2025, driven almost entirely by capitation revenue from its PACE model. Net loss narrowed sharply to $0.7 million from $35.3 million, and income before income taxes was $0.3 million versus a prior-year loss of $34.0 million.
Profitability metrics strengthened meaningfully on an operating basis: Adjusted EBITDA rose to $94.6 million from $34.5 million, lifting Adjusted EBITDA margin to 9.6% from 4.0%, while Center-level Contribution Margin increased to $227.8 million, or 23.0% of revenue, from $153.6 million, or 18.0%. Operating cash flow more than doubled to $64.7 million, and cash and cash equivalents increased to $97.9 million at June 30, 2026.
InnovAge ended the year serving approximately 8,230 participants across 20 centers and issued fiscal 2027 guidance for revenue of $1.05–$1.085 billion and Adjusted EBITDA of $105–$115 million, with expected member months of 101,000–102,500 and census of 8,625–8,850.
InnovAge Holding Corp. executive Paul Taheri, Chief Medical Officer, reported initial beneficial ownership on a Form 3. He holds 38,765 shares/units as Restricted Stock Units that will be settled in common stock upon vesting. This includes 17,361 RSUs vesting ratably over three years beginning January 27, 2027 and 21,404 RSUs vesting ratably over three years beginning July 22, 2027, in each case subject to his continued service with the company.
InnovAge Holding Corp. has filed a shelf registration to enable selling security holders to resell up to 112,988,070 shares of common stock from time to time. These are existing shares held primarily by TCO Group Holdings, L.P.; the company itself is not selling shares and will receive no proceeds from these resales.
As of April 30, 2026, InnovAge had 135,736,393 shares outstanding. Its stock trades on Nasdaq under the symbol INNV, with a July 30, 2026 last sale price of $11.60 per share. The filing may increase potential share overhang if large holders choose to sell.
InnovAge operates the Program of All-Inclusive Care for the Elderly (PACE), serving about 8,050 participants across 20 centers in six states, under capitated contracts with Medicare, Medicaid and other government payors. Key risks highlighted include dependence on a limited number of government payors, potential Medicaid cuts under the One Big Beautiful Bill Act, ongoing inspections and investigations, litigation and stockholder proceedings, concentration in Colorado, labor and inflation pressures, Nasdaq listing compliance, and its status as a controlled company with significant governance rights for its principal shareholders.
BLAIR PATRICK T reported acquisition or exercise transactions in this Form 4 filing.
Patrick T Blair, Chief Executive Officer of InnovAge Holding Corp., received a grant of 78,397 Restricted Stock Units (RSUs) of common stock on 2026-07-27. These RSUs will vest in three equal installments on each anniversary of the grant date, subject to his continued service. Following this award, he directly holds 751,047 shares of common stock.
Adams Benjamin C reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. reported that Chief Financial Officer Benjamin C. Adams received an equity award of 17,123 shares of common stock in the form of Restricted Stock Units. The RSUs vest in three equal annual installments, contingent on his continued service, resulting in 17,123 directly held reported shares.
DAMATO NICOLE reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. reported that chief legal officer Nicole Damato received a grant of 51,369 Restricted Stock Units (RSUs) on July 22, 2026. The RSUs will be settled in shares of common stock and will vest in three equal annual installments on the anniversary of the grant date, subject to her continued service. Following this award, her reported direct holdings total 328,711 shares of common stock.
Delk Meredith reported acquisition or exercise transactions in this Form 4 filing.
InnovAge Holding Corp. granted Chief Administrative Officer Meredith Delk an equity award of 42,808 Restricted Stock Units (RSUs) on 2026-07-22. The RSUs will be settled in common stock and vest in three equal annual installments on each anniversary of the grant date, contingent on Delk’s continued service. Following this award, Delk holds 42,808 RSUs reported as common stock directly.
InnovAge Holding Corp. chief executive officer Patrick T. Blair reported a tax-withholding disposition of 14,453 shares of common stock on July 16, 2026, at $11.87 per share. The shares were withheld to cover taxes upon restricted stock unit vesting, leaving him with 672,650 directly held shares and no open-market sale.